Selectis Health, Inc. (GBCS) Net margin 2017–2025
Selectis Health, Inc. (GBCS) net profit margin by fiscal year — reported net income divided by reported revenue.
-2.5%FY2025 · since FY2017: -95.7% → -2.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.5% | +3.7 pp |
| FY2024 | -6.1% | +4.7 pp |
| FY2023 | -10.8% | -4.9 pp |
| FY2022 | -5.9% | +1.8 pp |
| FY2021 | -7.7% | -21.8 pp |
| FY2020 | 14.1% | +26.6 pp |
| FY2019 | -12.4% | +42.5 pp |
| FY2018 | -55.0% | +40.8 pp |
| FY2017 | -95.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice